The future of science
Pfizer, funding cuts, tuition fees, social mobility and teaching time. What's going on?
In February, pharmaceutical firm Pfizer announced plans to close its Sandwich site in Kent, with the loss of 2400 jobs. This was due to the firm's profitability dropping, in part because of losing patent exclusivity on several blockbuster drugs.
Described as a 'body blow' to UK science by CEO of the Institute of Chemical Engineers David Brown, this will have far reaching consequences for chemistry students and teachers. Not only was Pfizer a large employer and host to students during their year in industry, the site had also developed links with local schools, helping teach Year 12.
Just 24 hours later, the Higher Education Funding Council for England (HEFCE) announced the grant pots for the next academic year. For the next year, £4339 million will be allocated for teaching, a four per cent reduction, while research funding (cut by six per cent) will now only be focussed on the 3* and 4* departments, leaving 2* departments - internationally recognised in terms of originality, significance and rigour - with no 'quality related' funding.
Thanks for using Education in Chemistry. You can view one Education in Chemistry article per month as a visitor.
Register for Teach Chemistry for free, unlimited access
Registration is open to all teachers and technicians at secondary schools, colleges and teacher training institutions in the UK and Ireland.
Get all this, plus much more:
- unlimited access to resources, core practical videos and Education in Chemistry articles
- teacher well-being toolkit, personal development resources and online assessments
- applications for funding to support your lessons
Already a Teach Chemistry member? Sign in now.
Not eligible for Teach Chemistry? Sign up for a personal account instead, or you can also access all our resources with Royal Society of Chemistry membership.